Get early access to Quin

Pioneer a diabetes breakthrough
Check your eligibility

Is this for you?

Shape the future of insulin management

Access our app, join our programme


By joining our research programme, you get early access to the Quin app and all its innovative new functionalities.


With you, we’ll be refining the way Quin considers all the different events that may be impacting your glucose level.


By joining you can help us build a groundbreaking medical device for the next 18 months.


Join a community of like-minded early adopters, looking for a new approach to diabetes management.

What does the app do?

Do you remember how much insulin you took for your birthday cake last year? Or for that 3pm coffee 2 weeks ago? What about the last time you went to the gym and had a stable outcome?
Quin does. It analyses your current situation, it’s also plays back those past decisions.

The app gathers knowledge about you, data about your insulin decisions, and the events that may have affected them. These decisions you’ve made based on your own intuition, Quin creates a collection of them in a quantifiable way.

Join now

Applying is simple

Answer a few questions

It’s super quick, we promise. We need to ensure Quin is the most useful to you, this is why the programme selection criteria are very specific.

Fill out the form

If you qualify we need to be able to contact you regarding the programme and Quin in general. That’s all we use you details for. Nothing else

Sign our agreement

We wouldn’t want someone else to benefit from all the work you’ve put in helping us build the app. Once we receive your application it takes up to 48 hours for us to process it and confirm whether you are selected.

Install Testflight

It’s an Apple app that is purposely created for people like you – early adopters, visionaries and beta testers. It allows you to then download our Quin app in all safety. You can download it the same way you download any other app, except you will need to accept an invitation to use it fully. We will send you one.

Accept the invitation

iTunes Connect will send you an invitation. It’s exclusive and you get to be part of it. It’s all managed by Apple so once you receive the invitation, it’s best to accept it quickly before it expires.

Download the Quin app

Just like you would any other app in the app store. That’s it! You’re in. We’ll send you additional information on how to navigate the app, what to do and how to get the most value out of it.


Guys, the app has been invaluable to me today! I accidentally injected nearly 50% more background insulin than I usually do. Just got my notification to say the rogue dose is nearly gone and I can finally breathe a sigh of relief!

I do kind of like that you’ve flipped it to lead with the dosing part of diabetes, as opposed to other apps that lead with BG readings, which seems kind of reactive.

My favourite thing about your app is that it has something that the others don’t take into account, which is when my insulin is at its peak.

About Quin

We’re a female-founded, digital health startup.

Quin helps people with insulin-treated diabetes make the best possible self-care decisions.

Our purpose is using science, design and engineering to create new knowledge and help researchers create more personalised treatments and cures. We call it turning human experience into science.

Our founder, Isabella Degen, who lives with diabetes, drives the vision and direction of the Quin app and our research to help unlock more personalised treatment solutions for people who take insulin.

About our Team

We’re a team of problem solvers, engineers, designers and scientists who strive for excellence in everything we do.

We don’t just see the obstacles, we engineer ways around them. We are going the extra mile to channel our love for users through our work, our product and our research.

We are funded by Innovate UK and are part of the prestigious KQ Labs accelerator run by the Francis Crick Institute. They believe in us and the possibilities for the new science we aim create. And we hope you will too.